Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q4 2015 · 10-K
Revenue$1.56M$1.56M−37.0% vs Q4 2014 Net Income-$2.76M-$2.76MN/M vs Q4 2014 EPS Diluted-$0.25-$0.25N/M vs Q4 2014 Gross Profit$765,000−27.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$4,522,000N/M Free Cash Flowderived-$4,589,000N/M Margins · derivedGross margin49.2%+6.5 pt vs Q4 2014
Operating margin-133.5%+41.2 pt vs Q4 2014
Net margin-177.1%+56.0 pt vs Q4 2014
ended Dec 31, 2015 · filed Mar 11, 2016 · 71 d after period end